International Clinical Trial: A study investigating the efficacy and safety of the combination of iparomlimab and tuvonralimab with or without chemotherapy in second-line and subsequent treatments for recurrent or metastatic head and neck squamous cell carcinoma

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122369) titled 'A study investigating the efficacy and safety of the combination of iparomlimab and tuvonralimab with or without chemotherapy in second-line and subsequent treatments for recurrent or metastatic head and neck squamous cell carcinoma' on April 13.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The Second Affiliated Hospital of Hainan Medical University

Condition: Recurrent or metastatic head and neck squamous cell carcinoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-13

Target Sample Size: One-armed:32;

Countries of Recruitment: China ...